Kaur, Ramanjot
Tchanque-Fossuo, Catherine
West, Kaitlyn
Hadian, Yasmin
Gallegos, Anthony
Yoon, Daniel
Ismailyan, Ligia
Schaefer, Saul
Dahle, Sara E. http://orcid.org/0000-0002-8358-5061
Isseroff, R. Rivkah
Funding for this research was provided by:
MERIT (eRA#: 1-IO1-CX-001503-01-A1)
Article History
Received: 28 October 2019
Accepted: 14 May 2020
First Online: 8 June 2020
Ethics approval and consent to participate
: Study approval was obtained from the IRB Human Studies Subcommittee at the Sacramento VA Medical Center (reference [CitationRef removed]–08-00792) on August 16, 2017. Any protocol or informed consent amendments will require the IRB’s approval. Routine auditing of this study will be performed by the Research Compliance Officer according to VA guidelines. All auditing will be independent of the investigators and the sponsor. The protocol identification number on ClinicalTrials.gov is NCT03282981. This study will be conducted in accordance with the medical professional codex and the Helsinki Declaration as of 1996 as well as Data Security Laws and Good Clinical Practice criteria.Written IRB-approved informed consent will be obtained from all subjects prior to enrollment, and subjects will be given adequate time to declare if they wish to participate in this study before signing the consent form. Study participation is voluntary and can be withdrawn at any time without provision of reason and without negative consequences for future medical care.
: Not applicable.
: The authors declare that they have no competing interests.